NCT00332631View on ClinicalTrials.gov

High-Dose N-Acetylcysteine in Cardiac Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

March 31, 2006

Conditions
Cardiac Surgery and Cardiopulmonary Bypass
Interventions
DRUG

N-acetylcysteine

DRUG

Placebo

Trial Locations (1)

3084

Austin Hospital, Melbourne

Sponsors

Lead Sponsor

Austin Health
All Listed Sponsors
lead

Austin Health

OTHER_GOV

NCT00332631 - High-Dose N-Acetylcysteine in Cardiac Surgery | Biotech Hunter | Biotech Hunter